Mark Welton) - 07 Mar 2024 Form 4 Insider Report for IMAX CORP (IMAX)

Role: President, IMAX Theatres
Signature: /s/ Kenneth I. Weissman (attorney-in-fact for Mark Welton)
Issuer symbol: IMAX
Transactions as of: 07 Mar 2024
Net transactions value: -$562,128
Form type: 4
Filing time: 11 Mar 2024, 16:50:10 UTC
Previous filing: 09 Mar 2023
Next filing: 09 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMAX	common shares	Options Exercise	$0	+14,734	+18%	$0.000000	97,005	07 Mar 2024	Direct	F1
transaction	IMAX	common shares	Options Exercise	$0	+11,957	+12%	$0.000000	108,962	07 Mar 2024	Direct	F1
transaction	IMAX	common shares	Options Exercise	$0	+12,957	+12%	$0.000000	121,919	07 Mar 2024	Direct	F1
transaction	IMAX	common shares	Tax liability	$356,580	-21,225	-17%	$16.80	100,694	07 Mar 2024	Direct	F2
transaction	IMAX	common shares	Award	$0	+22,856	+23%	$0.000000	123,550	07 Mar 2024	Direct	F3
transaction	IMAX	common shares	Tax liability	$205,548	-12,235	-9.9%	$16.80	111,315	07 Mar 2024	Direct	F4
holding	IMAX	common shares (opening balance)						82,271	07 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMAX	restricted share units	Options Exercise	$0	-14,734	-100%	$0.000000^*	0	07 Mar 2024	common shares	14,734	$0.000000	Direct	F1, F5, F6, F7, F11
transaction	IMAX	restricted share units	Options Exercise	$0	-11,957	-50%	$0.000000	11,959	07 Mar 2024	common shares	11,957	$0.000000	Direct	F1, F5, F6, F8, F11
transaction	IMAX	restricted share units	Options Exercise	$0	-12,957	-33%	$0.000000	25,916	07 Mar 2024	common shares	12,957	$0.000000	Direct	F1, F5, F6, F9, F11
transaction	IMAX	restricted share units	Award	$0	+42,975		$0.000000	42,975	07 Mar 2024	common shares	42,975	$0.000000	Direct	F5, F6, F10, F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the conversion upon vesting of restricted share units into common shares.
F2	Mr. Welton is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
F3	Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2021. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
F4	Mr. Welton is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance stock unit transactions.
F5	Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
F6	Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
F7	The restricted share units vest and will be converted to common shares in three installments: 14,733 on each of March 7, 2022 and March 7, 2023 and 14,734 on March 7, 2024.
F8	The restricted share units vest and will be converted to common shares in three installments: 11,957 on each of March 7, 2023 and March 7, 2024 and 11,959 on March 7, 2025.
F9	The restricted share units vest and will be converted to common shares in three installments: 12,957 on each of March 7, 2024 and March 7, 2025 and 12,959 on March 7, 2026.
F10	The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.
F11	This represents the number of restricted share units for this transaction only. Mr. Welton's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 88,936, 80,850 and 111,315, respectively. The number of outstanding options reflects the expiration of options to purchase 21,020 common shares on March 7, 2024. Mr. Welton did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d).